Shanghai Pharma targets Aussie vitamin maker

The Chinese pharmaceutical firm offers $238 million to take Vitaco private, in the latest example of China’s huge interest in clean and green food products.

Shanghai Pharma targets Aussie vitamin maker

China's insatiable appetite for all things Australian has seen it snap up everything from natural resources and real estate to airlines, hospitals and dairy farms. Vitamins are now on the list, too.

Shanghai Pharmaceuticals announced on Thursday it was teaming up with Chinese private equity firm Primavera Capital to acquire Sydney-listed Vitaco Holdings for A$314 million $238 million, just 10 months after the vitamins and health supplement maker made its debut on the...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Print Edition

FinanceAsia Print Edition

EVENTS